Thu, February 18, 2021
Wed, February 17, 2021
Tue, February 16, 2021

Cory Kasimov Downgraded (BLUE) to Hold and Decreased Target to $39 on, Feb 17th, 2021

Cory Kasimov of JP Morgan, Downgraded "bluebird bio, Inc." (BLUE) to Hold and Decreased Target from $76 to $39 on, Feb 17th, 2021.

Cory has made no other calls on BLUE in the last 4 months.



There are 6 other peers that have a rating on BLUE. Out of the 6 peers that are also analyzing BLUE, 2 agree with Cory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $50 on, Wednesday, November 11th, 2020
  • Matthew Luchini of "BMO Capital" Downgraded from Buy to Hold and Held Target at $56 on, Thursday, November 5th, 2020


These are the ratings of the 4 analyists that currently disagree with Cory


  • Yun Zhong of "Berenberg" Initiated at Strong Buy and Held Target at $64 on, Wednesday, November 11th, 2020
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $81 on, Thursday, November 5th, 2020
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $99 on, Thursday, November 5th, 2020
  • Difei Yang of "Mizuho" Initiated at Strong Buy and Held Target at $123 on, Tuesday, October 20th, 2020